Articles
Running biosimilar studies in the U.K. has been a challenge for many pharmaceutical companies who have often struggled to attract clinicians interested in supporting their biosimilar studies. This case study outlines the Covance approach to identify appropriate sites and how it used a national network to help advance a sponsor's biosimilar study in rheumatology.